73 related articles for article (PubMed ID: 1426792)
1. [Lack of tolerance after administration of delayed-action isosorbide-5-mononitrate for 3 days in patients with exercise-induced silent ischemia: control with placebo].
Scardi S; Pandullo C; Humar F; Spanghero M; Mazzone C
G Ital Cardiol; 1992 May; 22(5):549-57. PubMed ID: 1426792
[TBL] [Abstract][Full Text] [Related]
2. [Isosorbide-5-mononitrate in silent ischemia].
Pichler M; Brandt D; Teubl H; Dorda W
Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged treatment with isosorbide-5-mononitrate in patients with silent ischemia].
Almenar L; Gimeno JV; Palencia M; Algarra F
Rev Esp Cardiol; 1995 Jan; 48(1):49-54. PubMed ID: 7878282
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
6. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Parker JO
Am J Cardiol; 1993 Oct; 72(12):871-6. PubMed ID: 8213541
[TBL] [Abstract][Full Text] [Related]
7. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
9. [The effect on painful and silent myocardial ischemia of the preparations Efox and Efox Long in patients with stenocardia of effort].
Belousov IuB; Egorova NA; Karasev AV; Upnitskiĭ AA
Ter Arkh; 1997; 69(9):45-7. PubMed ID: 9411825
[TBL] [Abstract][Full Text] [Related]
10. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
11. [Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
Jansen W; Prenzel R; Kümper H; Weidmann B; Tauchert M
Z Kardiol; 1989; 78 Suppl 2():72-8; discussion 115-7. PubMed ID: 2511697
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina].
Lagioia R; Scrutinio D; Mangini SG; Mastropasqua F; Caporale R; Mancini G; Loliva F; Rizzon P
Cardiologia; 1989 Feb; 34(2):155-60. PubMed ID: 2660992
[TBL] [Abstract][Full Text] [Related]
13. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
14. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
[TBL] [Abstract][Full Text] [Related]
15. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI
Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090
[TBL] [Abstract][Full Text] [Related]
16. Sustained reduction of exercise perfusion defect extent and severity with isosorbide mononitrate (Imdur) as demonstrated by means of technetium 99m sestamibi.
Lewin HC; Hachamovitch R; Harris AG; Williams C; Schmidt J; Harris M; Van Train K; Siligan G; Berman DS
J Nucl Cardiol; 2000; 7(4):342-53. PubMed ID: 10958276
[TBL] [Abstract][Full Text] [Related]
17. The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.
Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Rehnqvist N; Ulvenstam G; Aberg A; Aström H
Eur Heart J; 1986 Oct; 7(10):835-42. PubMed ID: 3539613
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anti-ischemic effects of isosorbide-5-mononitrate, metoprolol and diltiazem: a study based on serial treadmill exercise test.
Gupta DK; Negi PC; Patial RK; Bansal SK
Indian Heart J; 1995; 47(5):485-8. PubMed ID: 8714503
[TBL] [Abstract][Full Text] [Related]
19. Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.
Stauch M; Grossmann G; Wanjura D; Adam WE
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S31-4. PubMed ID: 2354712
[TBL] [Abstract][Full Text] [Related]
20. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
